Survey and interview-based study on readiness of heart failure polypill implementation

20 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Raja Ezman Faridz Bin Raja Shariff

Universiti Teknologi MARA, Selangor (Malaysia)

7 More presentations in this session

Presentation thumbnail

Atrioventricular conduction disorders associated to betablocker treatment in patients with heart failure

Doctor D. Marcu (Iasi, RO)

Abstract Slides

Presentation thumbnail

The efficacy of combination therapy of corticosteroids and methotrexate for cardiac sarcoidosis, prolonged analysis

Doctor Y. Nishihata (Tokyo, JP)

Abstract Slides

Presentation thumbnail

Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy

Doctor A. Garcia (Lisbon, PT)

Abstract Slides

Presentation thumbnail

Telmisartan versus Enalapril in heart failure with reduced ejection fraction patients with moderately impaired kidney functions; randomized controlled trial. (TRIUMF trial)

Doctor S. Abouel Naga (Cairo, EG)

Abstract Slides

Presentation thumbnail

Meta-analysis on the role of potassium binders in optimization of guideline-directed medical therapy and safety outcomes in patients with heart failure

Doctor I. Tumang (Taguig, PH)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - pharmacotherapy 2

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources